$16,14
-$0,28(-1,70 %)
*Data last updated: 2026-04-29 09:20 (UTC+8)
As of 2026-04-29 09:20, Aurinia Pharmaceuticals (AUPH) is priced at $16,14, with a total market cap of $2,13B, a P/E ratio of 7,46, and a dividend yield of 0,00 %. Today, the stock price fluctuated between $16,05 and $16,42. The current price is 0,56 % above the day's low and 1,70 % below the day's high, with a trading volume of 823,22K. Over the past 52 weeks, AUPH has traded between $16,05 to $16,42, and the current price is -1,70 % away from the 52-week high.
AUPH Key Stats
Yesterday's Close$16,37
Market Cap$2,13B
Volumen823,22K
P/E Ratio7,46
Dividend Yield (TTM)0,00 %
Diluted EPS (TTM)2,13
Net Income (FY)$287,20M
Revenue (FY)$283,05M
Earnings Date2026-05-11
EPS Estimate0,18
Revenue Estimate$76,97M
Shares Outstanding130,29M
Beta (1Y)1.523
About AUPH
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
SectorHealthcare
IndustryBiotechnology
CEOKevin C. Tang
HeadquartersEdmonton,BC,CA
Official Websitehttps://www.auriniapharma.com
Employees (FY)128,00
Average Revenue (1Y)$2,21M
Net Income per Employee$2,24M
Aurinia Pharmaceuticals (AUPH) FAQ
What's the stock price of Aurinia Pharmaceuticals (AUPH) today?
x
Aurinia Pharmaceuticals (AUPH) is currently trading at $16,14, with a 24h change of -1,70 %. The 52-week trading range is $16,05–$16,42.
What are the 52-week high and low prices for Aurinia Pharmaceuticals (AUPH)?
x
What is the price-to-earnings (P/E) ratio of Aurinia Pharmaceuticals (AUPH)? What does it indicate?
x
What is the market cap of Aurinia Pharmaceuticals (AUPH)?
x
What is the most recent quarterly earnings per share (EPS) for Aurinia Pharmaceuticals (AUPH)?
x
Should you buy or sell Aurinia Pharmaceuticals (AUPH) now?
x
What factors can affect the stock price of Aurinia Pharmaceuticals (AUPH)?
x
How to buy Aurinia Pharmaceuticals (AUPH) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
